NewEdge Advisors LLC Sells 8,649 Shares of The Clorox Company $CLX

NewEdge Advisors LLC cut its holdings in The Clorox Company (NYSE:CLX) by 11.6% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 66,160 shares of the company’s stock after selling 8,649 shares during the quarter. NewEdge Advisors LLC’s holdings in Clorox were worth $6,856,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Caitlin John LLC increased its position in Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares in the last quarter. Darwin Wealth Management LLC acquired a new stake in Clorox in the second quarter valued at approximately $29,000. Vision Financial Markets LLC grew its stake in shares of Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after buying an additional 200 shares during the last quarter. Root Financial Partners LLC grew its stake in shares of Clorox by 83.8% during the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after buying an additional 145 shares during the last quarter. Finally, SHP Wealth Management acquired a new position in shares of Clorox during the fourth quarter worth $35,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 3.0%

Shares of NYSE:CLX opened at $96.69 on Friday. The firm has a market cap of $11.69 billion, a P/E ratio of 15.70 and a beta of 0.54. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $128.90. The business has a fifty day simple moving average of $95.49 and a 200 day simple moving average of $103.72.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s revenue was up .1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.45 EPS. Analysts predict that The Clorox Company will post 5.52 earnings per share for the current year.

Insider Activity

In related news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.63% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Royal Bank Of Canada dropped their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. Wells Fargo & Company dropped their target price on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. Citigroup reduced their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $94.00 price objective on shares of Clorox in a research note on Wednesday, July 22nd. Finally, Jefferies Financial Group lowered shares of Clorox from a “buy” rating to a “hold” rating and dropped their price objective for the company from $125.00 to $98.00 in a report on Tuesday. Twelve analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $101.00.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.